HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CAPER, a novel regulator of human breast cancer progression.

Abstract
CAPER is an estrogen receptor (ER) co-activator that was recently shown to be involved in human breast cancer pathogenesis. Indeed, we reported increased expression of CAPER in human breast cancer specimens. We demonstrated that CAPER was undetectable or expressed at relatively low levels in normal breast tissue and assumed a cytoplasmic distribution. In contrast, CAPER was expressed at higher levels in ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) specimens, where it assumed a predominantly nuclear distribution. However, the functional role of CAPER in human breast cancer initiation and progression remained unknown. Here, we used a lentiviral-mediated gene silencing approach to reduce the expression of CAPER in the ER-positive human breast cancer cell line MCF-7. The proliferation and tumorigenicity of MCF-7 cells stably expressing control or human CAPER shRNAs was then determined via both in vitro and in vivo experiments. Knockdown of CAPER expression significantly reduced the proliferation of MCF-7 cells in vitro. Importantly, nude mice injected with MCF-7 cells harboring CAPER shRNAs developed smaller tumors than mice injected with MCF-7 cells harboring control shRNAs. Mechanistically, tumors derived from mice injected with MCF-7 cells harboring CAPER shRNAs displayed reduced expression of the cell cycle regulators PCNA, MCM7, and cyclin D1, and the protein synthesis marker 4EBP1. In conclusion, knockdown of CAPER expression markedly reduced human breast cancer cell proliferation in both in vitro and in vivo settings. Mechanistically, knockdown of CAPER abrogated the activity of proliferative and protein synthesis pathways.
AuthorsIsabelle Mercier, Donna M Gonzales, Kevin Quann, Timothy G Pestell, Alexander Molchansky, Federica Sotgia, James Hulit, Ricardo Gandara, Chenguang Wang, Richard G Pestell, Michael P Lisanti, Jean-François Jasmin
JournalCell cycle (Georgetown, Tex.) (Cell Cycle) Vol. 13 Issue 8 Pg. 1256-64 ( 2014) ISSN: 1551-4005 [Electronic] United States
PMID24621503 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HCC1 autoantigen
  • Nuclear Proteins
  • Proliferating Cell Nuclear Antigen
  • Proto-Oncogene Proteins c-jun
  • RNA, Small Interfering
  • RNA-Binding Proteins
Topics
  • Animals
  • Breast Neoplasms (metabolism, pathology)
  • Cell Cycle Checkpoints
  • Cell Proliferation
  • Disease Progression
  • Female
  • Gene Knockdown Techniques
  • Humans
  • MCF-7 Cells
  • Mice, Nude
  • Neoplasm Transplantation
  • Nuclear Proteins (genetics, metabolism)
  • Phosphorylation
  • Proliferating Cell Nuclear Antigen (metabolism)
  • Protein Biosynthesis
  • Proto-Oncogene Proteins c-jun (metabolism)
  • RNA, Small Interfering (metabolism)
  • RNA-Binding Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: